Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Custodiol-N vs Custodiol in pediatric heart transplantation
NCT06032195Phase 2Recruiting
- Sponsor
- Franz Köhler Chemie
- Start
- Aug 2023
- Primary completion
- Jan 2027
- Modality
- Device-based Delivery
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of histidine-tryptophan-ketoglutarate solution (modified) (2 arms), sponsored by Franz Köhler Chemie. Primary endpoint: Adverse Events at 3 months. Started Aug 2023; status: recruiting.
02
Drugs
histidine-tryptophan-ketoglutarate solution (modified)
Beyond the preview
Go deeper on NCT06032195.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06032195.